Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with LLY as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|5.57%||iShares Dow Jones US Pharmaceuticals Index Fund (IHE)||+20.57 (15.03%)|
|5.04%||PowerShares Dynamic Pharmaceuticals Portfolio (PJP)||+7.58 (12.04%)|
|4.62%||Market Vectors Pharmaceutical ETF (PPH)||+4.54 (7.32%)|
|3.24%||SPDR S&P Pharmaceuticals ETF (XPH)||+8.97 (8.69%)|
|2.66%||First Trust Morningstar Dividend Leaders Index Fund (FDL)||+0.62 (2.60%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Eli Lilly and Company (the “company” or “registrant” or "Lilly") was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly. We discover, develop, manufacture, and market products in two business segments—human pharmaceutical products and animal health products. The mission of our human pharmaceutical business is to make medicines that help people live longer, healthier, more active lives. Our strategy is to create value for all our stakeholders by accelerating the flow of innovative new medicines that provide improved outcomes for individual patients. Most of the products we sell today were discovered or developed by our own scientists, and our success depends to a great extent on our ability to continue to discover, develop, and bring to market innovative new medicines. ... More ...
Where does LLY fit in the risk graph?
|Annual EPS Est:||$4.15|
|Quarterly EPS Est:||0.74|